Alan D. Frazier serves as Executive at Alexza Pharmaceuticals Inc., where they oversee executive responsibilities. Since joining the company, Alan D. Frazier has executed 17 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 19, 2014 involved transacting 4,796,711 shares valued at $67.2M.
Alan D. Frazier currently holds 4,894,035 shares of Alexza Pharmaceuticals Inc. (ALXA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alan D. Frazier has been a net neutral trader of ALXA stock. They have purchased $0 and sold $0 worth of shares.
Alan D. Frazier's most recent insider trade was on Mar 19, 2014, when they sold 4,796,711 shares at $14.00 per share.
Get notified when new Form 4 filings are submitted
| $14.00 |
| Discretionary |
| Feb 12, 2014 | CADX | $1.4M | Option Exercise | 173,792 | $7.84 | Discretionary |
| Feb 12, 2014 | CADX | $12.3M | Option Exercise | 1,564,129 | $7.84 | Discretionary |
| Feb 12, 2014 | CADX | $12.3M | Payment | 875,913 | $14.00 | Discretionary |
| Feb 12, 2014 | CADX | $1.4M | Payment | 97,324 | $14.00 | Discretionary |
| Jan 26, 2010 | ALXA | $0 | Award | 21,008 | $N/A | Discretionary |
| Feb 18, 2009 | CADX | $2.5M | Award | 347,584 | $7.13 | Discretionary |
| Feb 18, 2009 | CADX | $22.3M | Award | 3,128,258 | $7.13 | Discretionary |
| Jan 22, 2009 | ALXA | $0 | Award | 17,794 | $N/A | Discretionary |
| Feb 20, 2008 | CADX | $10.0M | Award | 1,872,659 | $5.34 | Discretionary |
| Oct 30, 2006 | CADX | $0 | Conversion | 2,500,000 | $N/A | Discretionary |
| Mar 13, 2006 | ALXA | $0 | Conversion | 8,054 | $N/A | Discretionary |
| Mar 13, 2006 | ALXA | $0 | Conversion | 4,390 | $N/A | Discretionary |
| Mar 13, 2006 | ALXA | $0 | Conversion | 583,931 | $N/A | Discretionary |
| Mar 13, 2006 | ALXA | $0 | Conversion | 1,586,752 | $N/A | Discretionary |
| Nov 28, 2005 | RIGL | $0 | Gift | 10,905 | $N/A | Discretionary |